Related Articles
EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapy
A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study
Postrecurrence survival of surgically resected pulmonary adenocarcinoma patients according to EGFR and KRAS mutation status
Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation‑positive non‑small cell lung cancer, receiving treatment with gefitinib or erlotinib
Differential efficacy of docetaxel according to non‑small cell lung cancer histology and the therapeutic effect of epidermal growth factor receptor tyrosine kinase inhibitors